Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes

被引:43
作者
Laloux, W
Beaudoin, L
Ronet, C
Lehuen, A
机构
[1] Hop Necker Enfants Malad, INSERM, Unite 25, F-75743 Paris 15, France
[2] Inst Pasteur, INSERM, Unite 277, Paris, France
关键词
D O I
10.4049/jimmunol.168.7.3251
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NKT cells are considered unconventional T cells. First, they are restricted by a nonclassical MHC class I molecule, CD1d, which presents glycolipids; second, their TCR repertoire is very limited. After stimulation by their TCR, NKT cells rapidly release large amounts of cytokines, such as IL-4 and IFN-gamma. Little is known about NKT cells present in lymph nodes. In the present report we show that NKT cells are differently distributed in various lymph nodes and are, for instance, abundant in pancreatic and mesenteric lymph nodes of C57BL/6 mice and nonobese diabetic mice. The high frequency of NKT cells in splanchnic lymph nodes is not simply a consequence of inflammatory signals, as draining lymph nodes still contain low frequencies of NKT cells after IFA or CFA injections. NKT cells from splanchnic lymph nodes harbor a Vbeta repertoire similar to that of splenic and liver NKT cells, in contrast to peripheral NKT cells that are not biased toward Vbeta8 segments. Analysis of cytokine production by NKT cells from splanchnic lymph nodes reveals that they produce at least as much IL-4 as IFN-gamma, in contrast to NKT cells from other organs (spleen, liver, and peripheral lymph nodes), which produce much more IFN-gamma than IL-4. These specific features of NKT cells from splanchnic lymph nodes might explain their protective action against the development of pathogenic Th1 cells in type 1 diabetes.
引用
收藏
页码:3251 / 3258
页数:8
相关论文
共 37 条
[1]  
ALARD P, 1993, BIOTECHNIQUES, V15, P730
[2]   Evidence for two subgroups of CD4-CD8- NKT cells with distinct TCRαβ repertoires and differential distribution in lymphoid tissues [J].
Apostolou, I ;
Cumano, A ;
Gachelin, G ;
Kourilsky, P .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2481-2490
[3]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[4]   CD1 RECOGNITION BY MOUSE NK1(+) T-LYMPHOCYTES [J].
BENDELAC, A ;
LANTZ, O ;
QUIMBY, ME ;
YEWDELL, JW ;
BENNINK, JR ;
BRUTKIEWICZ, RR .
SCIENCE, 1995, 268 (5212) :863-865
[5]  
Carnaud C, 1999, J IMMUNOL, V163, P4647
[6]   Protection against diabetes and improved NW/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex [J].
Carnaud, C ;
Gombert, JM ;
Donnars, O ;
Garchon, HJ ;
Herbelin, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2404-2411
[7]   Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors [J].
Cui, JQ ;
Shin, T ;
Kawano, T ;
Sato, H ;
Kondo, E ;
Toura, I ;
Kaneko, Y ;
Koseki, H ;
Kanno, M ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1623-1626
[8]   A role for CD4(+)NK1.1(+)T T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8(+) effector function against intracellular infection [J].
Denkers, EY ;
SchartonKersten, T ;
Barbieri, S ;
Caspar, P ;
Sher, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :131-139
[9]  
Eberl G, 1999, J IMMUNOL, V162, P6410
[10]   Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice:: A major role for bone marrow in NKT cell homeostasis [J].
Eberl, G ;
MacDonald, HR .
IMMUNITY, 1998, 9 (03) :345-353